Thanks to the thousands of doctors, patients and researchers that have chosen us, we have proven that our respiratory platform makes a difference to patients' lives.
*Based on pilot study with Royal Brompton Hospital in London. 41 patients, mean age 37.3 years (SD 10.2), mean FEV1 57.3% predicted (range 24.2–103.0). Length of time using NuvoAir platform: mean 13.0 months (range 6.9–25.8).
An integrated ecosystem tailored around respiratory health to improve the lives of those suffering from lung problems and support physicians in making better and faster clinical decisions.
Recognized with multiple international awards, simple-to-use for both young and seniors, FDA cleared and CE marked.
NuvoAir detects when your respiratory health is changing and provides you with contextually relevant insights so you can take action.
With NuvoAir your healthcare provider is always with you. Whether your are responding to a new treatment or you need instant care, we will let them know.
We are inspiring patients and physicians to achieve better respiratory health.
“My son uses NuvoAir as a reassurance, so if he's concerned he will check what his lung function is when he needs it.“
“NuvoAir has helped me to being more alert when I am sick, because I am able to check if my lung function is down. I feel it has really helped me identify infections earlier.“
“I can check how my lung function and symptoms are progressing together with my doctor to see if my medication is working“